inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take
Company profile
Ticker
INGN
Exchange
Website
CEO
Scott Wilkinson
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
SEC CIK
Corporate docs
Subsidiaries
Inogen Europe B.V. ...
INGN stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
18 Apr 24
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
8-K
Departure of Directors or Certain Officers
15 Apr 24
S-8
Registration of securities for employees
1 Mar 24
S-8
Registration of securities for employees
1 Mar 24
10-K
2023 FY
Annual report
1 Mar 24
8-K
Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results
27 Feb 24
8-K
Inogen Names Michael Bourque As New Chief Financial Officer
24 Jan 24
8-K
Departure of Directors or Certain Officers
5 Jan 24
Transcripts
INGN
Earnings call transcript
2023 Q4
27 Feb 24
INGN
Earnings call transcript
2023 Q3
7 Nov 23
INGN
Earnings call transcript
2023 Q2
7 Aug 23
INGN
Earnings call transcript
2023 Q1
4 May 23
INGN
Earnings call transcript
2022 Q4
23 Feb 23
INGN
Earnings call transcript
2022 Q3
2 Nov 22
INGN
Earnings call transcript
2022 Q2
7 Aug 22
INGN
Earnings call transcript
2022 Q1
7 May 22
INGN
Earnings call transcript
2021 Q4
25 Feb 22
INGN
Earnings call transcript
2021 Q3
6 Nov 21
Latest ownership filings
4
Michael J. Bourque
6 Mar 24
3
Michael J. Bourque
6 Mar 24
4
Jason Somer
5 Mar 24
4
Kevin Raymond Merrill Smith
5 Mar 24
4
Stanislav Glezer
5 Mar 24
SC 13G/A
BROWN CAPITAL MANAGEMENT LLC
14 Feb 24
SC 13G/A
Camber Capital Management LP
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
24 Jan 24
3
Gregoire Ramade
11 Jan 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 124.61 mm | 124.61 mm | 124.61 mm | 124.61 mm | 124.61 mm | 124.61 mm |
Cash burn (monthly) | 14.36 mm | 7.09 mm | 15.57 mm | 11.57 mm | (no burn) | 1.30 mm |
Cash used (since last report) | 95.83 mm | 47.28 mm | 103.93 mm | 77.24 mm | n/a | 8.66 mm |
Cash remaining | 28.78 mm | 77.32 mm | 20.68 mm | 47.37 mm | n/a | 115.95 mm |
Runway (months of cash) | 2.0 | 10.9 | 1.3 | 4.1 | n/a | 89.4 |
Institutional ownership, Q3 2023
90.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 127 |
Opened positions | 14 |
Closed positions | 25 |
Increased positions | 42 |
Reduced positions | 47 |
13F shares | Current |
---|---|
Total value | 106.58 bn |
Total shares | 21.02 mm |
Total puts | 1.60 k |
Total calls | 4.70 k |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
Brown Capital Management | 2.20 mm | $11.47 bn |
Camber Capital Management | 2.00 mm | $10.44 bn |
BLK Blackrock | 1.79 mm | $9.33 bn |
Vanguard | 1.35 mm | $7.06 bn |
Fred Alger Management | 1.06 mm | $5.55 bn |
ExodusPoint Capital Management | 800.01 k | $4.18 bn |
AMP Ameriprise Financial | 671.57 k | $3.51 bn |
Bridgeway Capital Management | 629.80 k | $3.29 bn |
Aqr Capital Management | 606.70 k | $3.17 bn |
Meros Investment Management | 589.60 k | $3.08 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Mar 24 | Michael J. Bourque | RSU Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 75,000 |
1 Mar 24 | Jason Somer | Common Stock | Payment of exercise | Dispose F | No | No | 7.025 | 4,576 | 32.15 k | 6,488 |
1 Mar 24 | Jason Somer | Common Stock | Option exercise | Acquire M | No | No | 0 | 7,150 | 0.00 | 11,064 |
1 Mar 24 | Jason Somer | RSU Common Stock | Grant | Acquire A | No | No | 0 | 21,996 | 0.00 | 21,996 |
1 Mar 24 | Jason Somer | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,680 | 0.00 | 9,359 |
1 Mar 24 | Jason Somer | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,894 | 0.00 | 1,893 |
1 Mar 24 | Jason Somer | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 576 | 0.00 | 3,459 |
1 Mar 24 | Smith Kevin Raymond Merrill | RSU Common Stock | Grant | Acquire A | No | No | 0 | 85,000 | 0.00 | 85,000 |
1 Mar 24 | Stanislav Glezer | Common Stock | Payment of exercise | Dispose F | No | No | 7.025 | 7,623 | 53.55 k | 16,106 |
1 Mar 24 | Stanislav Glezer | Common Stock | Option exercise | Acquire M | No | No | 0 | 13,914 | 0.00 | 23,729 |
News
Needham Reiterates Hold on Inogen
9 Apr 24
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
28 Feb 24
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
28 Feb 24
Why Is Inogen Stock Plummeting Today?
28 Feb 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
28 Feb 24
Press releases
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
10 Apr 24
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
25 Mar 24
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
7 Mar 24
Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
30 Jan 24
Inogen Names Michael Bourque as New Chief Financial Officer
24 Jan 24